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谱技术（HR-ESIMS，1H NMR，13C NMR，DEPT，2D NMR 等）对分离得到的
化合物进行结构鉴定，实验分离鉴定得到了 18 个化合物。其中的 6 个萜类化合
物通过 HSCCC 快速分离。参考萜类化合物的 HSCCC 溶剂体系，结合 TLC 和
HPLC 分析以及测定分配系数，筛选出正己烷/乙酸乙酯/甲醇/水体系作为溶剂系
统，并对溶剂系统和流速进行优化，成功应用 HSCCC 对卤地菊的石油醚部位化






5α-hydroxy-2-oxo-p-menth-6(1)-ene （ 2 ）、 5, 8-epoxynaphtho [2, 3-b] furan, 


























中分离得到。体外抗肿瘤研究表明，化合物 3 对 HepG-2 细胞、Hela 细胞、MCF7
细胞和 A549 细胞均具有一定的抑制作用（IC50＝2.76 μM，9.62 μM，5.49 μM，
4.18 μM），化合物 4 对 HepG-2 细胞、MCF7 细胞和 A549 细胞有较强的抑制作
用（IC50＝4.19 μM，1.87 μM，7.45 μM），化合物 5 对 Hela 细胞和 A549 细胞具
有较明显的抑制作用（IC50＝6.14 μM，8.76 μM）。化合物 13 对 HepG-2 细胞的
IC50 值为 2.47 μM，化合物 18 对 A549 细胞的 IC50 值为 5.16 μM，表明化合物 13
























 Wedelia prostrate (Hook. et Arn.) Hemsl, belonging to the Compositae family, 
was found in various areas in China. The chemical investigations of this genus 
indicated that diterpenes, sesquiterpenes, flavonoids, organic acids were its main 
components. To terpenoids, especially ent-kaurene diterpenoids, which were the 
primary constituents of Wedelia, different bioactivities had been attributed, including 
antibacterial, antiviral, antioxidant, anticancer, antiangiogenic and so on. 
 The present study was designed to investigate the chemical constituents from 
Wedelia prostrata and their cytotoxicity activity. The ethanol extract was suspended in 
H2O and partitioned in sequence using petroleum ether, EtOAc, and n-BuOH, 
respectively, to afford three kind extracts. The petroleum ether extract was separated 
and purified by the conventional separation technology such as silica gel column 
chromatography, polyamide column chromatography, gel column chromatography 
and semipreparative HPLC. Eighteen phytochemical compounds were isolated and 
their structures were unambiguously established by spectroscopic methods including 
HR-ESIMS and NMR spectrometry. And using HSCCC to separate and purify six 
terpenoids in eighteen compounds. By reference to HSCCC solvent system of other 
terpenoids, combined with analysis and determination of partition coefficient by TLC 
and HPLC, selecting n-hexane/ethyl acetate/methanol/water system as the solvent 
system and optimizing the volume ratio of solvent system and flow rate. The result 
demonstrates that six terpenoids can be obtained efficiently from the petroleum ether 
extract extracts using HSCCC. Then all compounds were evaluated for their 
cytotoxicities toward human HepG-2, Hela, MCF-7, and A549 cell lines by the MTT 
method. 
 From the petroleum ether extract of Wedelia prostrata, eighteenth phytochemical 
compounds were isolated and established: 3α-phenylpropionoyloxy-ent-kaur- 
16-en-oic acid (1), 5α-hydroxy-2-oxo-p-menth-6(1)-ene (2), 5, 8-epoxynaphtho [2, 
















propanoic acid derivatives (4), ent-kaur-16-en-19-oic acid (5), 3β-hydroxy-ent-kaur 
-16-en-oic acid (6), 3α-angeloyloxy-ent-kaur-16-en-oic acid (7), 3α-tigloyloxy 
-ent-kaur-16-en-oic acid (8), 3α-senecioyloxy-ent-kaur-16-en-oic acid (9), 
3α-angloyloxypterokaurene L3 (10), 3α-tigloyloxypterokaurene L3 (11), 
epifriedelanol (12), β-amyrin acetate (13), benzoic acid (14), caffeic acid (15), 
α-linolenic acid (16), β-sitosterol (17), luteolin (18). 3α-Phenylpropionoyloxy-ent- 
kaur-16-en-oic acid (1) was determined to be a new compound, five known terpenoids 
(2, 3, 9, 10 and 11) were isolated for the first time from the herbs of Wedelia prostrate. 
The cytotoxicity of compounds 1–18 from the petroleum ether extract of Wedelia 
prostrate were evaluated on HepG-2, Hela, MCF-7, and A549 cancer cells. 
Compound 3 revealed significant inhibitory activity against the proliferation of 
HepG-2, Hela, MCF-7, and A549 cells compared with positive control doxorubicin 
(IC50 = 2.76 μM, 9.62 μM, 5.49 μM, 4.18 μM). Compound 4 showed significant 
cytotoxicity on HepG-2, MCF-7, and A549 cell lines (IC50 = 4.19 μM, 1.87 μM, 7.45 
μM) and 5 showed cytotoxicity on Hela and A549 cell lines (IC50 = 6.14 μM, 8.76 
μM). Furthermore, compound 13 showed a significant cytotoxicity on HepG-2 with 
IC50 value of 2.47 μM and 18 showed a cytotoxicity on A549 with IC50 value of 5.16 
μM, which indicated that the compound 13 and 18 may have the selectivity on 
different tumor cell lines.  
 In summary, this study successfully isolated 18 compounds from Wedelia 
prostrate by the traditional technology and the HSCCC. To conduct the thorough 
research to the chemical constituents and pharmacological effects, further clarify the 
great significance of relationship between the chemical constituents and efficacy. The 
cytotoxicities of all compounds shows Wedelia prostrata will be certain potential and 
valuable in the anticancer research. 
 


















ODS      Octadecylsilyl 
PA      Polyamide 
MPLC      Medium pressure liquid chromatography 
HPLC      High performance liquid chromatography 
RP-HPLC     Reversed phase high performance liquid 
HSCCC     High-speed countercurrent chromatography 
Cross-axis CCC   Cross-axis counter current chromatography 
DuCCC     Dual counter current chromatography 
FCCC     Foam counter current chromatography 
pH-zone-refining CCC pH-zone-refining counter current chromatography 
HR-ESIMS    High resolution electronspray ionization-mass spectrum 
ESI-MS      Electronspray ionization-mass spectrum 
m/z       Mass-to-charge ratio 
IR        Infra-Red 
UV          Ultravolet 
NMR         Nuclear Magnetic Resonance 
1H NMR       1H nuclear magnetic resonance 
13C NMR      13C nuclear magnetic resonance 
DEPT         Distortionless enhancement by polarlization transfer 
HSQC         1H -detected heteronuclear single quantum correlation 
HMBC        l H -detected heteronuclear multiple-bond correlation 
COSY         Correlation Spectroscopy 
TOCSY         Total Correlation Spectroscopy 
DMSO         Dimethyl sulfoxide 
IC50     Half maximal inhibitory concentration 
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卤地菊（Wedelia prostrata（Hook. et Arn.）Hemsl.）为菊科蟛蜞菊属植物，
蟛蜞菊属约含植物 60 余种，分布于全世界亚热带和热带地区。在我国该属植物
除了卤地菊之外还有四种，分别是挛花蟛蜞菊（Wedelia biflora（L.）DC.）、麻













国内外对卤地菊的化学成分研究还较少，只有 24 种化合物被报道，包括 8 种倍
半萜内酯、8 种二萜（主要是对映-贝壳杉型二萜类）、3 种甾体、3 种环醇以及黄





























































流色谱技术和仪器设备。表 1.1 所列为逆流色谱的发展情况。 
 
表 1.1 逆流色谱的发展 
Table 1.1 Developments of CCC 
仪器名称 发明人 发明时间 
正交轴逆流色谱 
Cross-axis countercurrent chromatography[17-19] 
Ito 1988 
双向逆流色谱 
Dual countercurrent chromatography[20] 
Lee 1988 
泡沫逆流色谱 
Foam countercurrent chromatography[21] 
Ito 1985 
pH-区带精制逆流色谱 
pH-zone-refining countercurrent chromatography[22] 
Ito 1993 
 

























图 1.1 不同类型的逆流色谱的原理图 
（A）螺旋管行星式离心分离柱的原理示意图；（B）双向逆流色谱柱的示意图；（C）泡沫
逆流色谱柱的示意图；（D）pH-区带精制逆流色谱分离原理示意图 
Fig 1.1 Schematic diagram of different types of CCC 
(A)The synchronous planetary motion of a multilayer coil separation column; (B) Design of the 
coiled column for dual CCC; (C) Design of the coiled column for foam CCC; (D) Mechanism of 
pH-zone-refining CCC 
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